Re:Dementia risk linked to blood-protein imbalance in middle...
by wbl on Friday July 21, 2023 @01:09PM
(#36816506)
Always. Secondary endpoints are heavily disfavored in FDA approval.
[ Parent
| on HN ]
There are no comments on this comment yet.